Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
T

TCR2 Therapeutics Inc
F:2K7

Watchlist Manager
TCR2 Therapeutics Inc
F:2K7
Watchlist
Price: 1.442 EUR 3.07% Market Closed
Market Cap: €56.6m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-1%
5Y
-
10Y
-
Liabilities
+
3Y
+649%
5Y
-
10Y
-
Equity
+
3Y
-31%
5Y
-
10Y
-

Balance Sheet Decomposition
TCR2 Therapeutics Inc

Balance Sheet
TCR2 Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
8
20
48
65
94
223
33
Cash Equivalents
8
20
48
65
94
223
33
Short-Term Investments
8
0
76
93
134
43
116
Other Current Assets
1
1
2
5
8
11
28
Total Current Assets
17
21
126
163
236
276
178
PP&E Net
1
1
2
5
10
45
29
PP&E Gross
1
1
2
5
10
45
29
Accumulated Depreciation
0
1
1
2
3
5
6
Other Long-Term Assets
0
0
2
0
1
2
2
Total Assets
18
N/A
22
+20%
129
+488%
169
+30%
246
+46%
323
+31%
208
-36%
Liabilities
Accounts Payable
1
0
3
3
2
2
3
Accrued Liabilities
0
1
3
5
6
16
61
Short-Term Debt
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
1
Total Current Liabilities
1
1
6
8
9
19
64
Long-Term Debt
0
0
0
0
0
0
0
Other Liabilities
0
0
0
1
1
23
3
Total Liabilities
1
N/A
1
+30%
6
+354%
8
+37%
10
+19%
42
+336%
67
+61%
Equity
Common Stock
29
47
209
0
0
0
0
Retained Earnings
12
26
86
183
250
350
501
Additional Paid In Capital
0
0
0
343
486
631
643
Other Equity
0
0
0
0
0
0
0
Total Equity
17
N/A
21
+20%
124
+494%
160
+30%
237
+47%
281
+19%
141
-50%
Total Liabilities & Equity
18
N/A
22
+20%
129
+488%
169
+30%
246
+46%
323
+31%
208
-36%
Shares Outstanding
Common Shares Outstanding
23
23
24
24
34
38
39

See Also

Summary
2K7 intrinsic value, competitors valuation, and company profile.
DCF Valuation
2K7 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
2K7 stock valuation using valuation multiples.
Wall Street Estimates
2K7 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
2K7 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.